中洲控股(000042.SZ):南昌聯泰和深圳聯泰解押及質押均為4320萬股
格隆匯 3 月 5日丨中洲控股(000042.SZ)公佈,公司於2021年3月5日收到公司股東南昌聯泰投資有限公司(“南昌聯泰”)和深圳市聯泰房地產開發有限公司(“深圳聯泰”)的吿知函,吿知公司南昌聯泰將所持有的3250萬股公司流通股股份、深圳聯泰將所持有的1070萬股公司流通股股份於2021年3月5日在中國證券登記結算有限責任公司深圳分公司辦理完解除質押登記手續,隨後南昌聯泰及深圳聯泰於2021年3月5日將上述公司流通股股份在中國證券登記結算有限責任公司深圳分公司辦理完質押登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.